Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways

被引:11
|
作者
Therachiyil, Lubna [1 ,2 ]
Hussein, Ola J. [1 ]
Uddin, Shahab [2 ,3 ]
Korashy, Hesham M. [1 ,4 ]
机构
[1] Qatar Univ, Coll Pharm, Dept Pharmaceut Sci, QU Hlth, Doha, Qatar
[2] Hamad Med Corp, Translat Res Inst, Acad Hlth Syst, Doha, Qatar
[3] Hamad Med Corp, Dermatol Inst, Acad Hlth Syst, Doha, Qatar
[4] Qatar Univ, Coll Pharm, Doha, Qatar
关键词
Aryl hydrocarbon receptor; Chemoresistance; Gynecological cancers; Stemness markers; Cancer stem cells; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN OVARIAN-CANCER; SIDE-POPULATION CELLS; BREAST-CANCER; ENDOMETRIAL CANCER; ALDEHYDE DEHYDROGENASE; AH-RECEPTOR; STEM/PROGENITOR CELLS; MULTIDRUG-RESISTANCE; TRANSCRIPTION FACTOR;
D O I
10.1016/j.semcancer.2022.10.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gynecological malignancies are a female type of cancers that affects the reproductive system. Cancer metastasis or recurrence mediated by cellular invasiveness occurs at advanced stages of cancer progression. Cancer Stem Cells (CSCs) enrichment in tumors leads to chemoresistance, which results in cancer mortality. Exposure to environmental pollutants such as polycyclic aromatic hydrocarbons is associated with an increased the risk of CSC enrichment in gynecological cancers. One of the important pathways that mediates the metabolism and bioactivation of these environmental chemicals is the transcription factor, aryl hydrocarbon receptor (AhR). The present review explores the molecular mechanisms regulating the crosstalk and interaction of the AhR with cancer-related signaling pathways, such as apoptosis, epithelial-mesenchymal transition, immune checkpoints, and G-protein-coupled receptors in several gynecological malignancies such as ovarian, uterine, endometrial, and cervical cancers. The review also discusses the potential of targeting the AhR pathway as a novel chemo-therapy for gynecological cancers.
引用
收藏
页码:1186 / 1202
页数:17
相关论文
共 50 条
  • [21] Immunobiology and signaling pathways of cancer stem cells: implication for cancer therapy
    Salem, Mohamed L.
    El-Badawy, Ahmed S.
    Li, Zihai
    CYTOTECHNOLOGY, 2015, 67 (05) : 749 - 759
  • [22] The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells
    Elizabeth A. Stanford
    Zhongyan Wang
    Olga Novikov
    Francesca Mulas
    Esther Landesman-Bollag
    Stefano Monti
    Brenden W. Smith
    David C. Seldin
    George J. Murphy
    David H. Sherr
    BMC Biology, 14
  • [23] Modulation of Aryl Hydrocarbon Receptor (AhR) Signaling in Mesenchymal Stem Cells by Tryptophan Metabolites
    Alhamad, Dima
    Bensreti, Husam
    Ellingwood, Ashley
    Dorn, Jennifer
    Bollag, Wendy
    Fulzele, Sadanand
    Isales, Carlos
    Hill, William
    Hamrick, Mark
    McGee-Lawrence, Meghan
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 343 - 343
  • [24] Biomarkers and signaling pathways of colorectal cancer stem cells
    Abetov, Danysh
    Mustapova, Zhanar
    Saliev, Timur
    Bulanin, Denis
    TUMOR BIOLOGY, 2015, 36 (03) : 1339 - 1353
  • [25] Cancer stem cells: Signaling pathways and therapeutic targeting
    Talukdar, Joyeeta
    Srivastava, Tryambak P.
    Sahoo, Om S.
    Karmakar, Abhibroto
    Rai, Avdhesh K.
    Sarma, Anupam
    Gogoi, Gayatri
    Alqahtani, Mohammed S.
    Abbas, Mohamed
    Dhar, Ruby
    Karmakar, Subhradip
    MEDCOMM-ONCOLOGY, 2023, 2 (04):
  • [26] Editorial: Exploring cancer stem cells signaling pathways
    Mekapogu, Alpha R.
    Suarez, Cecilia A.
    Wang, Jenny Y.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] Endometrial Cancer Stem Cells Related Signaling Pathways
    Pour, Fatemeh Khojasteh
    Keivan, Mona
    Ghaedrahmati, Farhoodeh
    Saadati, Najmieh
    Moramezi, Farideh
    Nikbakht, Roshan
    Farzaneh, Maryam
    CURRENT CANCER THERAPY REVIEWS, 2023, 19 (04) : 284 - 291
  • [28] Cancer Stem Cells and Targeting Embryonic Signaling Pathways
    Ullmann, Claudio Dansky
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S492 - S494
  • [29] Aryl hydrocarbon receptor agonists inhibit EGFR/HER4 signaling in breast cancer cells
    Yamashita, Naoya
    Kanno, Yuichiro
    Kizu, Ryoichi
    CANCER SCIENCE, 2022, 113 : 1536 - 1536
  • [30] Targeting notch signaling and estrogen receptor pathways in human breast cancer stem cells
    Luraguiz, N. S.
    Yong, T.
    Yin, H.
    Sun, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)